Trials / Completed
CompletedNCT02515864
Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)
A Crossover Study to Assess the Effects of FYU-981 on the QT/QTc Interval in Healthy Male and Female Volunteers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Fuji Yakuhin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A Placebo-controlled, Four Way Crossover Study to Investigate the Effect on QT/QTc Interval of a Single Dose of FYU-981, Compared with Placebo, Using Moxifloxacin as a Positive Control, in Healthy Male and Female Volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FYU-981 | |
| DRUG | Placebo | |
| DRUG | Moxifloxacin | |
| DRUG | Moxifloxacin Placebo |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-03-01
- Completion
- 2016-11-01
- First posted
- 2015-08-05
- Last updated
- 2017-09-08
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02515864. Inclusion in this directory is not an endorsement.